Cinzia Aurilia

8PUBLICATIONS
53CO-AUTHORS
Molecular medicineGene and molecular therapyPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Multiphysics flows (incl. multiphase and reacting flows)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Edoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo

|Sep 28, 2024
Calcitonin Gene-Related Peptide Monoclonal Antibodies: Key Lessons from Real-World Evidence.

Bianca Orlando, Gabriella Egeo, Cinzia Aurilia

|Jul 27, 2024
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE-The First Italian Multicenter, Prospective, Real-Life Study.

Piero Barbanti, Bianca Orlando, Gabriella Egeo

|Apr 18, 2023
Late Response to Anti-CGRP Monoclonal Antibodies in Migraine: A Multicenter Prospective Observational Study.

Piero Barbanti, Cinzia Aurilia, Gabriella Egeo

|Nov 26, 2022
Association of LTA and SOD Gene Polymorphisms with Cerebral White Matter Hyperintensities in Migraine Patients.

Patrizia Ferroni, Raffaele Palmirotta, Gabriella Egeo

|Jun 28, 2022
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience.

Claudia Altamura, Nicoletta Brunelli, Marilena Marcosano

Pageof 2

Frequent Collaborators

6 joint publications

Piero Barbanti

4 joint publications

Gabriella Egeo

4 joint publications

Sabina Cevoli

3 joint publications

Maria Albanese